Comments*

 
  • Life Sciences & Biomedical Research

  • Featured Event

    Green Buildings and Health: From the Lab to the Real World

    Wednesday, December 14, 2016 | 6:00 PM - 8:30 PM
    The New York Academy of Sciences

    Researchers at Harvard T.H. Chan School of Public Health and SUNY Upstate Medical University present the results of a new study showing that employees in high-performing, green-certified buildings had higher cognitive function test scores than those in similarly high-performing buildings that were not green certified, even after controlling for other potential explanatory factors.

  • Events 

    Monday, June 5, 2017 | 12:30 PM - 5:30 PM

    2017 Ross Prize in Molecular Medicine — Regulating Immunity: Fc Receptor Biology

    Featuring: Jeffrey V. Ravetch (The Rockefeller University)

    The Ross Prize in Molecular Medicine was established in conjunction with the Feinstein Institute for Medical Research and Molecular Medicine.

    June 13 - 14, 2017

    Neuroplasticity, Neuroregeneration, and Brain Repair

    Keynote Speaker: Michael V. Sofroniew (David Geffen School of Medicine at UCLA)

    The conference will explore neuroregenerative processes and identify strategies for translating knowledge into treatments for neurodegenerative diseases and nervous system injuries.

    Monday, June 19, 2017 | 1:30 PM - 6:00 PM

    Genome Integrity Discussion Group

    Keynote Speaker: Stephen J. Elledge (Harvard Medical School)

    The Genome Integrity Discussion Group provides a forum for interactions between basic and clinical research groups working on chromosome biology and function, and at the interface between chromosome integrity and onset and progression of malignancy.

    June 21 - 22, 2017

    The Need to Accelerate Therapeutic Development — Must Randomized Controlled Trials Give Way?

    Experience a public-facing dialogue exploring the nuanced ethical and scientific rationale behind randomized controlled clinical trials, accelerated alternatives, and the implications of these discussions on drug approval and patient interests.

    Tuesday, September 26, 2017 | 9:00 AM - 5:00 PM

    Targeting RNA Using Small Molecules

    Speakers: Nathan J. Baird (National Heart, Lung and Blood Institute, NIH), Matthew D. Disney (Scripps Research Institute), John A. Howe (Merck Research Laboratories), David H. Mathews (University of Rochester), Kevin M. Weeks (University of North Carolina at Chapel Hill), Steven C. Zimmerman (University of Illinois), and John S. Schneekloth, Jr. (National Cancer Institute)

    This symposium will cover approaches for targeting RNA with small and large molecules. The relevance of RNA splicing, microRNA, and RNA repeat expansions to human disease, and novel approaches for selectively modulating RNA function will be discussed.

  • Past Events

    Thursday, May 25, 2017 | 9:00 AM - 5:00 PM

    Targeting Cancer Metabolism and Signaling

    Keynote Speaker: Craig Thompson (Memorial Sloan Kettering Cancer Center)

    This symposium will highlight insights into tumor metabolism from leaders in the field and explore how this information is being used to design safe and effective, metabolism-targeted therapies.

    Wednesday, May 24, 2017 | 12:00 PM - 5:00 PM

    Chemical Biology Discussion Group Year-End Symposium

    Speakers: Sean F. Brady (The Rockefeller University), Dirk Trauner (New York University)

    The Chemical Biology Discussion Group brings together chemists and biologists interested in discussing the latest breakthroughs. In 2017, the annual year-end meeting features keynote speakers Dr. Sean F. Brady and Dr. Dirk Trauner.

    May 15 - 17, 2017

    13th International Conference on Myasthenia Gravis and Related Disorders

    Keynote Speaker: Vijay K. Kuchroo (Harvard Institutes of Medicine)

    Learn about most recent advances in basic, translational, and clinical research on the rare, acquired disorder, Myasthenia Gravis, as well as implications of this research on a range of related autoimmune and neuromuscular diseases.

    Tuesday, April 25, 2017 | 9:00 AM - 5:00 PM

    Complement Pathways in Disease

    Keynote Speaker: V. Michael Holers (University of Colorado School of Medicine)

    The complement system is the first line of defense against infection, however we have yet to capitalize on its therapeutic potential. This symposium will focus on novel insights into the complement pathway in a number of clinical disorders.

  • Publications 

    Annals

    Special Issue: Women's and Adolescent Nutrition

    Edited by Ann NY Acad Sci editorial staff

    Scholarly papers exploring healthy nutritional status among adolescents and young women

    eBriefing

    Alzheimer's Disease as a Neurovascular Inflammatory Disorder

    Keynote Speaker: Costantino Iadecola (Weill Cornell Medicine)

    This eBriefing covers the basic research and clinical science elucidating such mechanisms that underlie the contribution of inflammatory pathways to vascular cognitive impairment and dementia.

    Annals

    Special Issue: The Potential of Pulses to Meet Today's Health Challenges

    Edited by Annals of the New York Academy of Sciences editorial staff.

    The United Nations declared 2016 as the International Year of Pulses (IYP) to highlight the importance of increasing pulse production and consumption

    eBriefing

    Microbial Influences in Cardio–Metabolic Diseases

    Featuring: Henrik Bjørn Nielsen (Clinical-Microbiomics A/S), Martin J. Blaser (New York University Langone Medical Center), Patrice D. Cani (Universite Catholique de Louvain, LDRI), Rachel Carmody (Harvard University), Stanley L. Hazen (Cleveland Clinic), Gerald I. Shulman (Yale University School of Medicine), Marion Soto (Joslin Diabetes Center, Harvard Medical School), and Dan Winer (University of Toronto)

    The microbiome is emerging as an important regulator of health and disease well beyond the digestive tract. This eBriefing surveys highlights from recent research innovations and therapeutic applications from the microbiome with a focus on metabolic disease.